SCHEMBL4772461

SCHEMBL4772461

O=C(C1CCCNC1)C1CCCNC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 3/20 0.71
TSHR P16473 2/20 0.71
SLC6A11 P48066 2/20 0.71
SLC6A13 Q9NSD5 2/20 0.71
LMNA P02545 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.71
KDM4E B2RXH2 1/20 0.68
MAPT P10636 1/20 0.68
KMT2A Q03164 1/20 0.68
ATM Q13315 1/20 0.68
CYP2D6 P10635 1/20 0.68
NOS2 P35228 1/20 0.56
CHRNB2 P17787 2/20 0.41
CHRNB4 P30926 2/20 0.41
CHRNA3 P32297 2/20 0.41
CHRNA4 P43681 2/20 0.41
CHRNA7 P36544 1/20 0.41
APLNR P35414 2/20 0.40
CPN1 P15169 2/20 0.40
CPB2 Q96IY4 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27891040 0.98 SLC6A1 (0.68) SLC6A1TSHRSLC6A11SLC6A13LMNA
SCHEMBL27643059 0.93 SLC6A1 (0.61) SLC6A1TSHRSLC6A11SLC6A13LMNA
SCHEMBL28824479 0.84 GABRA5 (0.52) SLC6A1TSHRSLC6A11SLC6A13LMNA
SCHEMBL28023799 0.84 GABRA5 (0.52) SLC6A1TSHRSLC6A11SLC6A13LMNA
SCHEMBL2146157 0.84 SLC6A1 (0.52) SLC6A1TSHRSLC6A11SLC6A13LMNA
SCHEMBL2146162 0.84 SLC6A1 (0.52) SLC6A1TSHRSLC6A11SLC6A13LMNA
(R)-Nipecotic Acid SCHEMBL520075 0.83
(R)-Nipecotic Acid SCHEMBL29880539 0.83
(S)-Nipecotic Acid SCHEMBL254683 0.83
Nipecotic Acid SCHEMBL85677 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008140810-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-11-20 WO claimed
EP-1962846-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-09-03 EP claimed
WO-2007059323-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-24 WO claimed
CN-105209436-B 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists 南洋理工大学 2019-02-01 CN disclosed
CN-105209436-B 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists 南洋理工大学 2019-02-01 CN disclosed
CN-105209436-B 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists 南洋理工大学 2019-02-01 CN disclosed
CN-105693598-B A kind of method that iridium catalytic hydrogenation synthesizes 3 derivative of piperidone 中国科学院大连化学物理研究所 2017-12-19 CN disclosed
CN-102015683-A Substituted indole derivatives GRUENENTHAL GMBH 2011-04-13 CN disclosed
WO-2008140810-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-11-20 WO disclosed
CN-1901910-A Substituted piperidine compounds for the treatment of metabolic syndrome ASTRAZENECA AB (SE) 2007-01-24 CN disclosed